Frequent Links
Multivariate-data-analysis-Scholarly-journal-Neurobiology Peer-review JournalsPaper Chromatography Top Open Access JournalsHealth-economics-Online-JournalsInfectious diseasesArticles on Rheumatic diseasesDepression prader willi syndrome peer review journalsSocial and Environmental AccountingRecombineering High Impact Factor JournalsBiotransformation of ToxicantsPolitical Violence Impact factorAIDS Top Journals Neurochemistryopen access articles on pharmacology
Butofilolol
File:Butofilolol skeletal.svg | |
Systematic (IUPAC) name | |
---|---|
(RS)-1-[2-[3-(tert-butylamino)-2-hydroxypropoxy]-5-fluorophenyl]butan-1-one | |
Clinical data | |
Identifiers | |
64552-17-6 7px | |
None | |
PubChem | CID 68838 |
ChemSpider | 62071 7px |
UNII | 4AZC6Y5A8G 7px |
ChEMBL | CHEMBL157443 7px |
Synonyms | CM-6805 |
Chemical data | |
Formula | C17H26FNO3 |
311.392 g/mol | |
| |
14px (what is this?) (verify) |
Butofilolol (trade name Cafide) is a beta-blocker drug for the treatment of essential hypertension (high blood pressure).[1][2] It is not known to be marketed anywhere.
References
- ^ Houin, G; Barre, J; Jeanniot, JP; Ledudal, P; Cautreels, W; Tillement, JP (1984). "Pharmacokinetics of butofilolol (CAFIDE) after repeated oral administration in man". International journal of clinical pharmacology research 4 (3): 175–83. PMID 6149195.
- ^ Toussain, P; Gay, G; Debry, G (1983). "Long-term hypotensive treatment by butofilolol". Annales de cardiologie et d'angeiologie 32 (4): 277–83. PMID 6412614.
Lua error in package.lua at line 80: module 'Module:Buffer' not found.